Impact Programs
Addressing the full spectrum of childhood cancer challenges.
.png)
Impact Programs
CoLab's Impact Programs reflect our comprehensive, patient-centred approach, and ensure every aspect of childhood cancer, from diagnosis through to survivorship, is supported by world-class research and innovation.
Major Partners
Transforming childhood cancer outcomes in Australia takes vision, collaboration, and serious investment.
With significant funding commitments from the Victorian Government and Children's Cancer Foundation, we are building something Australia has never had before — a coordinated and collaborative approach to childhood cancer research that is strategic, accountable, and relentlessly focused on outcomes.
Strategic approach to funding
To ensure we only fund high-impact collaborative research and innovation, Children's Cancer CoLab is underpinned by five funding principles.
Patient-driven
Every aspect of our organisation, from setting Impact Program priorities to funding decisions, incorporates patient, survivor, and family perspectives.
Strategic and tactical
Our strategic funding approach avoids duplication, breaks down silos, and dynamically allocates resources where they will have the greatest impact.
Independent and transparent
Independent national and international experts rigorously review all proposals for scientific merit, clinical impact, and alignment with strategic priorities.
Collaborative
We prioritise collaboration in the projects we support and our overall approach. By actively partnering with a diverse range of stakeholders, we ensure our efforts remain responsive to evolving needs.
Milestone-based funding
Funding is released in stages, with regular reviews to ensure measurable,
high-impact outcomes. This allows us to support pilot studies or high-risk,
high-reward research projects.
We collaborate with:
Your support can make a difference
By supporting Children's Cancer CoLab, you become part of a community breaking traditional barriers to accelerate research discoveries, creating real impact for young cancer patients and their families.
